Special Issue "Ocular Drug Delivery"

Quicklinks

A special issue of Pharmaceutics (ISSN 1999-4923).

Deadline for manuscript submissions: closed (30 December 2011)

Special Issue Editor

Guest Editor
Prof. Dr. Alon Harris
Highly Cited - Thomson Reuters

Director of Clinical Research, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, 702 Rotary Circle, Room 137, Indianapolis, IN 46202, USA
Website: http://iueye.iu.edu/faculty1/alon-harris-ph-d-farvo/
Fax: +1 317 278 1007
Interests: glaucoma; diabetes; age-related macular degeneration; vascular; blood flow; ischemia; perfusion; treatments

Keywords

  • glaucoma
  • diabetes
  • age-related macular degeneration
  • vascular
  • blood flow
  • ischemia
  • perfusion
  • treatments

Published Papers (5 papers)

Download All Papers
Sort by:
Display options:
Select articles Export citation of selected articles as:
Select/unselect all
Displaying article 1-5
p. 252-275
by , ,  and
Pharmaceutics 2012, 4(2), 252-275; doi:10.3390/pharmaceutics4020252
Received: 8 February 2012 / Revised: 17 April 2012 / Accepted: 5 May 2012 / Published: 14 May 2012
Show/Hide Abstract | Cited by 4 | PDF Full-text (687 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Ocular Drug Delivery)
p. 243-251
by ,  and
Pharmaceutics 2012, 4(1), 243-251; doi:10.3390/pharmaceutics4010243
Received: 14 February 2012 / Revised: 29 February 2012 / Accepted: 14 March 2012 / Published: 21 March 2012
Show/Hide Abstract | Cited by 6 | PDF Full-text (96 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Ocular Drug Delivery)
p. 230-242
by , , , ,  and
Pharmaceutics 2012, 4(1), 230-242; doi:10.3390/pharmaceutics4010230
Received: 7 February 2012 / Revised: 28 February 2012 / Accepted: 9 March 2012 / Published: 15 March 2012
Show/Hide Abstract | PDF Full-text (227 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Ocular Drug Delivery)
abstract graphic
p. 212-229
by , , , , ,  and
Pharmaceutics 2012, 4(1), 212-229; doi:10.3390/pharmaceutics4010212
Received: 13 February 2012 / Revised: 29 February 2012 / Accepted: 29 February 2012 / Published: 12 March 2012
Show/Hide Abstract | Cited by 1 | PDF Full-text (3246 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Ocular Drug Delivery)
p. 197-211
by , , , , ,  and
Pharmaceutics 2012, 4(1), 197-211; doi:10.3390/pharmaceutics4010197
Received: 22 December 2011 / Revised: 6 February 2012 / Accepted: 1 March 2012 / Published: 8 March 2012
Show/Hide Abstract | Cited by 10 | PDF Full-text (175 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Ocular Drug Delivery)
Select/unselect all
Displaying article 1-5
Select articles Export citation of selected articles as:

Last update: 4 March 2014

Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert